Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - PLx Pharma Inc.ex_266816.htm
EX-31.2 - EXHIBIT 31.2 - PLx Pharma Inc.ex_266815.htm
EX-31.1 - EXHIBIT 31.1 - PLx Pharma Inc.ex_266810.htm
10-Q - FORM 10-Q - PLx Pharma Inc.plxp20210630_10q.htm

Exhibit 10.1

 

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT

 

This SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (the “Second Amendment”) is made and entered into as of August 3, 2021, by and between Rita O’Connor (the “Executive”) and PLx Pharma Inc., a Delaware corporation (the “Company”) for the purpose of amending that one certain Employment Agreement, dated May 1, 2017, by and between the parties, as previously amended (the “Agreement”).

 

NOW, THEREFORE, in consideration of the mutual covenants, promises and obligations set forth herein and the Agreement, the parties agree as follows:

 

Section 4.2(a) of the Agreement is hereby amended in its entirety, effective as of the date of this Second Amendment, to read as follows:

 

(a) a single payment in amount equal to one hundred fifty percent (150%) of Executive’s Base Salary in effect as of the Termination Date;

 

Except as expressly amended by this Second Amendment, the parties do hereby ratify and confirm the Agreement in its entirety.

 

Terms not defined in this Second Amendment shall have the meanings set forth in the Agreement.

 

IN WITNESS WHEREOF, the parties hereto have executed this Second Amendment as of the date first above written.

 

 

PLX PHARMA INC.

 

 

 

By:    /s/ Natasha Giordano                  

Natasha Giordano

President & CEO

   

 

 

EXECUTIVE

 

 

 

Signature:   /s/ Rita OConnor                   

Print Name: Rita O’Connor